INSP — Inspire Medical Systems Cashflow Statement
0.000.00%
Last trade - 00:00
- $6.94bn
- $6.48bn
- $624.80m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -33.2 | -57.2 | -42 | -44.9 | -21.2 |
Depreciation | |||||
Non-Cash Items | 6.48 | 14.2 | 27.6 | 52.8 | 83.7 |
Other Non-Cash Items | |||||
Changes in Working Capital | -6.57 | -10.9 | -6.86 | 1.81 | -40.8 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Cash from Operating Activities | -32.8 | -53 | -20.1 | 11.6 | 24.7 |
Capital Expenditures | -2.74 | -2.46 | -4.67 | -9.1 | -23.6 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | -40.8 | 89.1 | 33.8 | -10.5 | -271 |
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Cash from Investing Activities | -43.6 | 86.6 | 29.1 | -19.6 | -295 |
Financing Cash Flow Items | -0.531 | 0 | 0 | -0.043 | -17.2 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 1.96 | 134 | 14.9 | 235 | 13.9 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -74.4 | 168 | 23.9 | 227 | -256 |